A singleplex real-time PCR-based in vitro diagnostic assay for the simultaneous quantitative detection and differentiation of HIV-1 and HIV-2 RNA in plasma and serum. Enables accurate viral load measurement and supports early diagnosis, treatment monitoring, and disease management with clinical-grade precision.
Human Immunodeficiency Virus (HIV) is a retrovirus that attacks the immune system, specifically CD4+ T-cells, leading to immune deficiency and susceptibility to opportunistic infections. Untreated infection progresses to Acquired Immunodeficiency Syndrome (AIDS).
HIV exists as two distinct types: HIV-1, the predominant global strain, and HIV-2, which is primarily prevalent in West Africa. Accurate detection and differentiation of both types is critical for appropriate treatment selection and clinical management.
The Genplex™ HIV 1&2 RT-PCR Kit enables simultaneous detection and differentiation of HIV-1 and HIV-2 RNA in a single assay, providing quantitative viral load results for monitoring treatment efficacy, evaluating disease progression, and guiding antiretroviral therapy (ART) decisions.
Advanced molecular diagnostic capabilities engineered for clinical excellence and research-grade precision.
Simultaneously detects and differentiates HIV-1 and HIV-2 RNA in a single assay for accurate clinical management.
Sensitivity ≥98% ensures reliable quantification even at very low RNA concentrations in patient specimens.
Covers low to high HIV RNA concentrations, supporting early-stage diagnosis and high viral load monitoring.
Four calibrated standards (QS1–QS4) with defined HIV RNA concentrations for reliable viral load quantification.
Validated on ThermaCyte X16 & X96 (Probgen) and most open RT-PCR platforms.
Built-in IC monitors extraction efficiency and inhibition in every reaction, preventing false negatives.
Designed for diverse diagnostic and research use cases across the clinical spectrum.
Quantitative viral load measurement for HIV diagnosis, immune status assessment, and disease staging.
Monitor antiretroviral treatment (ART) response and detect virological failure early.
Differentiate between HIV-1 and HIV-2 to guide appropriate treatment regimens.
Screening blood donations for HIV RNA to minimize transfusion-transmitted infection risk.
| Parameter | Value / Description |
|---|---|
| Target Pathogen | HIV-1 RNA & HIV-2 RNA |
| Assay Type | Singleplex Quantitative RT-PCR (Dual Detection) |
| Sample Type | Plasma, Serum |
| Sensitivity | ≥ 98% |
| Internal Control | Included in every reaction |
| Standards | 4 Quantification Standards (QS1–QS4) |
| Compatible Instruments | ThermaCyte X16, ThermaCyte X96, and most open RT-PCR platforms |
| Intended Use | In Vitro Diagnostic (IVD) |
| Storage | -20°C |
For in vitro diagnostic use. Contact your regional distributor or ProbGen representative to place an order.
| Product Name | Cat. No. | Pack Size |
|---|---|---|
| Genplex™ HIV 1&2 Singleplex RT-PCR KIT | GP1028 | 48 tests |
| Genplex™ HIV 1&2 Singleplex RT-PCR KIT | GP1029 | 96 tests |
Contact our scientific team for technical specifications, bulk pricing, or to request a demonstration of our diagnostics solutions.
Contact Us All Products